Cocktail modulator mixtures for overcoming multidrug resistance in renal cell carcinoma

Urology

Volumn 54, Issue 2, 1999, Pages 377-381

  Yu, Dah Shyong ^a   Sun, Guang Huan ^a   Ma, Cheng Ping ^a   Chang, Sun Yran ^a  

^a Uro Oncology Laboratory   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIINFECTIVE AGENT; ANTIMYCIN A1; CALCIUM ANTAGONIST; CYCLOHEXIMIDE; DICOUMAROL; DOXORUBICIN; EMETINE; GLUTATHIONE TRANSFERASE; GRAMICIDIN; IONOPHORE; OLIGOMYCIN; OUABAIN; PAPAVERINE; PROTEIN KINASE C INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; PUROMYCIN; QUINIDINE; ROTENONE; TAMOXIFEN; UNCOUPLING PROTEIN; VERAPAMIL; VINBLASTINE;

ARTICLE; AUTOFLUORESCENCE; CYTOTOXICITY; DRUG ACCUMULATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MODULATION; NITROBLUE TETRAZOLIUM TEST; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, RENAL CELL; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; KIDNEY NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0032783822     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)00126-0     Document Type: Article

References (27)

1. Fojo A.T., Ueda K., Slamon D.J., et al. Expression of a multidrug-resistance gene in human tumors and tissues. Proc Natl Acad Sci USA. 84:1987;265-269.
2. Kartner N., Riordan J.R., Ling V. Cell surface P glycoprotein associated with multidrug resistance in mammalian cell lines. Science. 221:1983;1285-1288.
3. Dalton W.S., Durie B.G.M., Alverto D.S., et al. Characterization of a new drug-resistance human myeloma cell line that express P-glycoprotein. Cancer Res. 46:1986;5125-5130.
4. Hamada H., Tsuruo T. Characterization of the ATPase activity of Mr 170,000 to 180,000 membrane glycoprotein associated with multidrug resistance in K562/ADM cells. Cancer Res. 48:1988;4926-4932.
5. Kartner N., Evernden-Porelle D., Bradley G., et al. Detection of p-glycoprotein in multidrug-resistant cell lines by monoclonal antibodies. Nature. 316:1985;820.
6. Gottesman M.M., Pastan I. The multidrug transporter, a double-edged sword. J Biol Chem. 263:1988;1263-1265.
7. Benson M.C., Giella J., Whang I.S., et al. Flow cytometric determination of the multidrug resistance phenotype in transitional cell cancer of the bladder: implications and applications. J Urol. 146:1991;982-987.
8. Mickisch G.H., Roehrich K., Koessig J., et al. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J Urol. 144:1990;755-759.
9. Ahn H., Lee E., Kim K., et al. Effect of glutathione and its related enzymes on chemosensitivity of renal cell carcinoma and bladder carcinoma cell lines. J Urol. 151:1994;263-266.
10. Volm M., Kastel M., Mattern J., et al. Expression of resistance factors (p-glycoprotein, glutathione S-transferase-π, and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinomas. Cancer. 71:1993;3981-3985.
11. Flens M.J., Izquierdo M.A., Scheffer G.L., et al. Immunochemical detection of the multidrug resistance-associated protein MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res. 54:1994;4557-4560.
12. Mickisch G.H., Koessig J., Keilhauer G.K., et al. Effects of calcium antagonists in multidrug resistant primary human renal cell carcinomas. Cancer Res. 50:1990;3670-3674.
13. Mickisch G.H., Roehrich K., Koessig J., et al. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. J Urol. 144:1990;755-759.
14. Mickisch G.H., Kossig J., Tschada R.K., et al. Circumvention of multidrug resistance mediated by p-170 glycoprotein using calcium antagonists in primary human renal cell carcinoma. Urol Int. 47:1991;118-121.
15. Mickisch G., Bier H., Tschada R., et al. Effects of buthionine sulfoximine mediated glutathione depletion in chemoresistant human renal cell carcinomas. Jocham D., Thuroff J.W., Rubben H. Investigative Urology. 1992;21-34 Springer-Verlag, Berlin.
16. Yu D.-S., Chang S.-Y., Ma C.-P. The effect of methylene blue-sensitized photodynamic treatment on bladder cancer cells: a further study on flow cytometric basis. J Urol. 149:1993;1198-1201.
17. Yu D.-S., Chang S.-Y., Ma C.P. The correlation of membranous glycoprotein-gp-170, cytoplasmic glutathione and glucose-6-phosphate dehydrogenase levels with multidrug resistance in transitional cell carcinoma cell lines of the urinary tract. J Urol. 157:1997;727-731.
18. Carmichael J., DeGraff W.G., Gazdar A.F., et al. Evaluation of a tetrazolium-based semiautomated colorimetric assay assessment of chemosensitivity testing . Cancer Res. 47:1987;936-940.
19. Yu D.-S., Chang S.-Y., Yang T.-H., et al. The expression of MDR-1-related glycoprotein (gp-170) in normal kidney tissue and renal cell carcinoma. J Surg Assoc ROC. 30:1997;143-148.
20. Posada J., Vichi P., Tritton T.R. Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells. Cancer Res. 49:1989;6634-6638.
21. Gollapudi S., Patel K., Jain V., et al. Protein kinase C isoforms in multidrug resistant P388/ADR cells: a possible role in daunorubicin transport. Cancer Lett. 62:1991;69-72.
22. Ahmad S., Safa A.R., Glazer R.I. Modulation of p-glycoprotein by protein kinase C-alpha in a baculovirus expression system. Biochemistry. 33:1994;10313-10316.
23. Ma L., Krishnamachary N., Center M. Phosphorylation of the multidrug resistance-associated protein gene encoded protein p190. Biochemistry. 34:1995;3338-3342.
24. Taniguchi H., Pyerin W. Glutathione S-transferase is an in vitro substrate of Ca++-phospholipid-dependent protein kinase (protein kinase C). Biochem Biophys Res Commun. 162:1989;903-907.
25. Shayoun N., Wolf M., Besterman J. Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester induced differentiation of HL-60 cells. Proc Natl Acad Sci USA. 83:1986;1603-1606.
26. Aquino A., Hartman K.D., Knode M.C., et al. Role of protein kinase C in phosphorylation of vinculin in adriamycin-resistant HL-60 leukemia cells. Cancer Res. 48:1988;3324-3328.
27. Kawamura K. Features of filamentous cytoskeletons in acquired multidrug resistance of HL60 human leukemia cell line. Hokkaido J Med Sci. 69:1994;354-358.